Three vaccination doses to be considered ‘up-to-date’: ATAGI

By Jackson Graham

February 11, 2022

All people 16+ who have received a booster dose are considered ‘up-to-date’.  (Prostock-studio/Adobe)

People who receive three doses of a COVID-19 vaccine are set to be considered being ‘up-to-date’ in Australia but a national mandate will only cover aged care workers, a national cabinet meeting decided. 

Federal, state and territory leaders met on Thursday and discussed new Australian Technical Advisory Group on Immunisation advice that all individuals aged 16 years and over should receive a booster dose to be considered ‘up-to-date’. 

Once a person has completed their primary two doses, they will be considered ‘overdue’ if they haven’t received a booster within six months.

The status will only apply in domestic contexts with the commonwealth maintaining its definition of ‘fully vaccinated’ for the purposes of overseas travel and arrivals into Australia as requiring two doses of an approved vaccine. 

“People entering Australia will not be required to have had a booster dose of a COVID-19 vaccine,” a national cabinet statement following the meeting said. 

The meeting also endorsed the Australian Health Protection Principal Committee view that boosters should be mandatory in aged care facilities, with the requirement to now be consistent across state and territories. 

ATAGI said in its recommendation that people who had recovered from COVID were still recommended to get a booster dose. 

“Early preprint evidence indicates that prior infection with the Delta or earlier variants is not completely protective against re-infection with the Omicron variant,” the expert advisory group said. 

The Department of Health is also due to present a winter national COVID and influenza preparedness report to the next national cabinet meeting, after prime minister Scott Morrison requested it. 


TGA approves booster dose, minister expects early November rollout

About the author
Inline Feedbacks
View all comments
The Mandarin Premium

Insights & analysis that matter to you

Subscribe for only $5 a week


Get Premium Today